Articles from BIOTECH Patent News (October 1, 2005)

Title	Author	Type	Words
Arena issued patent for 5-HT2C receptor modulators for treatment of obesity.			607
Bayer CropScience obtains United States patent.		Brief Article	73
Bayer Pharmaceuticals obtains United States patent.			162
Bio-Rad signs collaboration agreement with Caliper to investigate microfluidic system.			294
BioGenex wins staining system patent suit against Ventana.			702
Bionomics granted patent for anti-cancer compounds.			413
Boston Scientific wins appeal in patent infringement case against Johnson & Johnson in the Netherlands.			342
CalbaTech's LifeStem files patent application for stem cell microbank.			370
Cambridge Antibody acquires oncology product candidates from Genencor.			974
Columbia obtains United States patent.			60
Columbia obtains United States patent.		Brief Article	213
CRYO-CELL signs exclusive license to market new stem cell service.		Company Profile	1021
DDS amplifies details of marketing and disaggregation license agreement with Xethanol.			642
Forest and Lundbeck announce Lexapro patent litigation trial date rescheduled.			82
Geron obtains United States patent.		Brief Article	98
Greengene Biotech obtains United States patent.			44
Human Genome Sciences obtains United States patent.			89
Human Genome Sciences obtains United States patent.			69
iCAD collaborates with George Washington University to bring digital breast cancer screening to D.C.			567
Incorporated Administrative Agency National Agriculture and Bio-Oriented Research Organization obtains United States patent.			90
Nabi strengthens patent portfolio for gram-positive franchise with patent for staphylococcal antigen and vaccine.			983
Nanogen announces patent for fluorescent detection of nucleic acid targets.			323
Oncolytics announces issuance of second Canadian patent - therapeutic use of the reovirus for cellular proliferative disorders including cancer.			257
Oncolytics announces issuance of third Canadian patent covering use of the reovirus to treat cancers.			167
Princeton obtains United States patent.			144
Salk Institute obtains United States patent.		Brief Article	163
SGC acquires stem cell intellectual properties.			507
Sontra and EpiVax to develop therapeutic topical vaccines.			441
Stressgen's European patent upheld against Antigenics' challenge.			457
Syngenta obtains United States patent.			124
Third wave files patent suits against Digene, Chiron and Bayer.			336
Two patents strengthen EntreMed's position in antiangiogenic drugs.			578
University of California obtains United States patent.			42
University of Hong Kong obtains United States patent.		Brief Article	86
VNUS files venous reflux disease patent infringement lawsuits against AngioDynamics.			180